期刊文献+

EV71疫苗的研究进展 被引量:6

An Overview of the Evolution of EV71 Vaccine
原文传递
导出
摘要 EV71引起的手足口病(HFMD)已经严重威胁婴幼儿的健康,但目前仍无特效抗病毒药物问世。许多科技工作者正在研发各种类型的EV71疫苗,包括灭活疫苗、类病毒颗粒疫苗、合成肽疫苗、DNA疫苗及转基因口服疫苗。本文就EV71疫苗的研究进展做一简要综述并对各自优劣和发展前景进行讨论。 EV71 infection has become a serious public health threat especially among young children.Yet,at present,no specific antiviral drug against EV71 infection is available.A number of scientists are studying various kinds of vaccines,including inactivated vaccine,virus-like particle vaccine,DNA vaccine, synthetic peptide vaccines,and transgenic oral vaccine.This article reviews the recent advancement in the design of various kinds of vaccine against EV71 as well as their prospective usefulness,effectiveness,weakness and developments in the foreground.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2010年第4期933-936,共4页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(30400402 30571708) 国家科技支撑计划资助项目(2006BAI03B12)
关键词 手足口病 EV71 疫苗 Hand-foot-mouth disease(HFMD) Enterovirus 71(EV71) Vaccine
  • 相关文献

参考文献28

  • 1PATEL K P, BERGELSON J M. Receptors identified for hand, foot and mouth virus [J]. Nat Med, 2009, 7(15) :728- 729.
  • 2SCHMIDT N J. An apparently new enterovirus isolated from patients with disease of the central nervous system [J]. J Infect Dis, 1974, 129:304-309.
  • 3QIU J. Enterovirus 71 infection:a new threat to global public health[J]? Lancet Neurol, 2008, 7:868-869.
  • 4MCMINN P C. An overview of the evolution of enterovirus 71 and its clinical and public health significance[J]. FEMS Microbiology Reviews, 2002, 26 : 91-107.
  • 5CHANG L Y. Enterovirus 71 in Taiwan [J]. Pediatr Neonatol, 2008, 49(4),103-112.
  • 6QIU J. Outbreak in China tests government efforts [J]. Nature, 2009, 458:554-555.
  • 7YANG F, REN L L, XIONG Z H, et al. Enterovirus 71 outbreak in the people's republic of China in 2008 [J].J Clin Microbiol, 2009, 47(7) :2351-2352.
  • 8CHUMAKOV M, VOROSHILOVA M, SHINDAROV L, et al. Enterovirus 71 isolated From cases of epidemic poliomyelitls-like disease in bulgaria [J]. Archives of Virology, 1979, 60,329-340.
  • 9WU C N, LIN Y C, FANN C, et al. Protection against Lethal enterovirus 71 infection in newborn mice by passive immunization with SubunitVP1 vaccines and inaetivated Virus [J]. Vaccine, 2002, 20..895-904.
  • 10LIN Y C, WU C N, SHIH S R, et al. Characterization of a vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate [J]. Vaccine, 2002, 20:2485- 2493.

同被引文献68

  • 1杨秀惠,何家鑫,严延生,何爱华,沈晓娜,陈前进.一起手足口病暴发的病原学诊断与分析[J].中国人兽共患病学报,2007,23(4):323-326. 被引量:60
  • 2中华人民共和国卫生部.肠道病毒71型(EV71)感染重症病例临床救治专家共识(2011年版),2011-04.
  • 3中华人民共和国卫生部.手足口病预防控制指南(2010年版).2008-04-20.
  • 4Bible JM, Pantelidis P, Chan PK, et al. Genetic evolution ofenterovirus 71: epidemiologieal and pathological implications. Rev Med Virol, 2007,17 ( 6 ) : 371-379.
  • 5Chen SC, Chang HL, Yan TR, et al. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am J Trop Med Hyg,2007,77 ( 1 ) : 188-191.
  • 6Tan EL, Yong LL, Quak SH, et al. Rapid detcetion of enterovirus 71 by real-time TaqMan RT-PCR. J Clin Virol, 2008,42 (2): 203 -206.
  • 7Nishimura Y, Wakita T, Shimizu H. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog,2010,6 ( 11 ) : 1371-1379.
  • 8Chu P Y,Ke G M, Chen Y S. et al. Molecular epidemiology ofcoxsackievirus B3[J]. Infect Genet Evol,2010 ,10(6) : 777 -84.
  • 9Bailey J M, Tapprich W E. Structure of the 5' nontranslated re-gion of the coxsackievirus B3 genome : chemical modification andcomparative sequence analysis [J]. Virology, 2007 , 81(2) : 650-68.
  • 10Yue Y, Xu W, Hu L, et al. Enhanced resistance to coxsackievir-us B3 induced m yocarditis by intranasal coimmunization of lym-photact in gene encapsulated inchitosan particle [J]. Virology,2009,386(2) :438 -47.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部